Year |
Citation |
Score |
2023 |
Hider RC, Pourzand C, Ma Y, Cilibrizzi A. Optical Imaging Opportunities to Inspect the Nature of Cytosolic Iron Pools. Molecules (Basel, Switzerland). 28. PMID 37764245 DOI: 10.3390/molecules28186467 |
0.62 |
|
2023 |
Jin J, Mazzacuva F, Crocetti L, Giovannoni MP, Cilibrizzi A. PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes. International Journal of Molecular Sciences. 24. PMID 37511275 DOI: 10.3390/ijms241411518 |
0.586 |
|
2023 |
Ran Y, Moursy M, Hider RC, Cilibrizzi A. The Colorimetric Detection of the Hydroxyl Radical. International Journal of Molecular Sciences. 24. PMID 36835574 DOI: 10.3390/ijms24044162 |
0.46 |
|
2022 |
Crocetti L, Floresta G, Zagni C, Merugu D, Mazzacuva F, de Oliveira Silva RR, Vergelli C, Giovannoni MP, Cilibrizzi A. Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2)-one as Novel Scaffold for FABP4 Inhibition. Pharmaceuticals (Basel, Switzerland). 15. PMID 36355506 DOI: 10.3390/ph15111335 |
0.622 |
|
2022 |
Crocetti L, Quinn MT, Cilibrizzi A, Giovannoni MP. Editorial: Serine protease inhibitors and their therapeutic applications. Frontiers in Chemistry. 10: 980152. PMID 36003619 DOI: 10.3389/fchem.2022.980152 |
0.558 |
|
2022 |
Floresta G, Memdouh S, Pham T, Ma MT, Blower PJ, Hider RC, Abbate V, Cilibrizzi A. Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes. Dalton Transactions (Cambridge, England : 2003). PMID 35972045 DOI: 10.1039/d2dt00980c |
0.656 |
|
2022 |
Crocetti L, Floresta G, Cilibrizzi A, Giovannoni MP. An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022. Molecules (Basel, Switzerland). 27. PMID 35956914 DOI: 10.3390/molecules27154964 |
0.577 |
|
2022 |
Cilibrizzi A, Wang JT, Memdouh S, Iacovone A, McElroy K, Jaffar N, Young JD, Hider RC, Blower P, Al-Jamal K, Abbate V. PSMA-targeted NIR probes for image-guided detection of prostate cancer. Colloids and Surfaces. B, Biointerfaces. 218: 112734. PMID 35952398 DOI: 10.1016/j.colsurfb.2022.112734 |
0.625 |
|
2022 |
Cilibrizzi A, Pourzand C, Abbate V, Reelfs O, Versari L, Floresta G, Hider R. The synthesis and properties of mitochondrial targeted iron chelators. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. PMID 35366134 DOI: 10.1007/s10534-022-00383-8 |
0.616 |
|
2021 |
Young JD, Ma MT, Eykyn TR, Andrew Atkinson R, Abbate V, Cilibrizzi A, Hider RC, Blower PJ. Corrigendum to "Dipeptide inhibitors of the prostate specific membrane antigen (PSMA): A comparison of urea and thiourea derivatives" [Bioorganic Med. Chem. Lett. 42 (2021) 128044]. Bioorganic & Medicinal Chemistry Letters. 48: 128231. PMID 34229996 DOI: 10.1016/j.bmcl.2021.128231 |
0.587 |
|
2021 |
Vergelli C, Khlebnikov AI, Crocetti L, Guerrini G, Cantini N, Kirpotina LN, Schepetkin IA, Cilibrizzi A, Quinn MT, Rossi P, Paoli P, Giovannoni MP. Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors (FPRs) agonists. Chemical Biology & Drug Design. PMID 34148303 DOI: 10.1111/cbdd.13913 |
0.638 |
|
2021 |
Young JD, Ma MT, Eykyn TR, Atkinson RA, Abbate V, Cilibrizzi A, Hider RC, Blower PJ. Dipeptide Inhibitors of the Prostate Specific Membrane Antigen (PSMA): A Comparison of Urea and Thiourea Derivatives. Bioorganic & Medicinal Chemistry Letters. 128044. PMID 33865971 DOI: 10.1016/j.bmcl.2021.128044 |
0.657 |
|
2020 |
Czerwinska J, Parkin MC, Cilibrizzi A, George C, Kicman AT, Dargan PI, Abbate V. Pharmacokinetics of Mephedrone Enantiomers in Whole Blood after a Controlled Intranasal Administration to Healthy Human Volunteers. Pharmaceuticals (Basel, Switzerland). 14. PMID 33374623 DOI: 10.3390/ph14010005 |
0.486 |
|
2020 |
O'Keeffe R, Latunde-Dada GO, Chen YL, Kong XL, Cilibrizzi A, Hider RC. Glutathione and the intracellular labile heme pool. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. PMID 33301081 DOI: 10.1007/s10534-020-00274-w |
0.651 |
|
2020 |
Gacesa R, Tripodi AAP, Cilibrizzi A, Leggio A, Hider R, Abbate V. Solid-Phase Synthesis and Analysis of Iron-Binding Catecholato Chelators. International Journal of Molecular Sciences. 21. PMID 33053658 DOI: 10.3390/ijms21207498 |
0.663 |
|
2020 |
Nielsen CD, Dhasmana D, Floresta G, Wohland T, Cilibrizzi A. Illuminating the Path to Target GPCR Structures and Functions. Biochemistry. PMID 32956586 DOI: 10.1021/Acs.Biochem.0C00606 |
0.309 |
|
2020 |
Chuljerm H, Deeudom M, Fucharoen S, Mazzacuva F, Hider RC, Srichairatanakool S, Cilibrizzi A. Characterization of two siderophores produced by Bacillus megaterium: A preliminary investigation into their potential as therapeutic agents. Biochimica Et Biophysica Acta. General Subjects. 1864: 129670. PMID 32565293 DOI: 10.1016/J.Bbagen.2020.129670 |
0.546 |
|
2020 |
Floresta G, Crocetti L, Giovannoni MP, Biagini P, Cilibrizzi A. Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening. Journal of Enzyme Inhibition and Medicinal Chemistry. 35: 1137-1144. PMID 32367744 DOI: 10.1080/14756366.2020.1760261 |
0.639 |
|
2020 |
Poeschl A, Mountford DM, Hider RC, Cilibrizzi A. Synthetic Approaches for Piperidone-Based Templates as Scaffolds to Access Chirally Enriched Donepezil Analogues. Acs Omega. 5: 2378-2396. PMID 32064399 DOI: 10.1021/acsomega.9b03808 |
0.481 |
|
2019 |
Chuljerm H, Chen YL, Srichairatanakool S, Hider RC, Cilibrizzi A. Synthesis and iron coordination properties of schizokinen and its imide derivative. Dalton Transactions (Cambridge, England : 2003). PMID 31742278 DOI: 10.1039/C9Dt02731A |
0.68 |
|
2019 |
Reelfs O, Abbate V, Cilibrizzi A, Pook MA, Hider RC, Pourzand C. The role of mitochondrial labile iron in Friedreich's ataxia skin fibroblasts sensitivity to ultraviolet A. Metallomics : Integrated Biometal Science. PMID 30778428 DOI: 10.1039/C8Mt00257F |
0.629 |
|
2019 |
Floresta G, Cilibrizzi A, Abbate V, Spampinato A, Zagni C, Rescifina A. FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets. Data in Brief. 22: 471-483. PMID 30619925 DOI: 10.1016/J.Dib.2018.12.047 |
0.607 |
|
2019 |
Cilibrizzi A, Floresta G, Abbate V, Giovannoni MP. iVS analysis to evaluate the impact of scaffold diversity in the binding to cellular targets relevant in cancer. Journal of Enzyme Inhibition and Medicinal Chemistry. 34: 44-50. PMID 30362379 DOI: 10.1080/14756366.2018.1518960 |
0.725 |
|
2018 |
Floresta G, Cilibrizzi A, Abbate V, Spampinato A, Zagni C, Rescifina A. 3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation. Bioorganic Chemistry. 84: 276-284. PMID 30529845 DOI: 10.1016/J.Bioorg.2018.11.045 |
0.608 |
|
2018 |
Ferraro G, Pica A, Petruk G, Pane F, Amoresano A, Cilibrizzi A, Vilar R, Monti DM, Merlino A. Preparation, structure, cytotoxicity and mechanism of action of ferritin-Pt(II) terpyridine compound nanocomposites. Nanomedicine (London, England). PMID 30501559 DOI: 10.2217/Nnm-2018-0259 |
0.58 |
|
2018 |
Cilibrizzi A, Abbate V, Chen YL, Ma Y, Zhou T, Hider RC. Hydroxypyridinone Journey into Metal Chelation. Chemical Reviews. PMID 30033720 DOI: 10.1021/Acs.Chemrev.8B00254 |
0.757 |
|
2018 |
Ferraro G, Marzo T, Infrasca T, Cilibrizzi A, Vilar R, Messori L, Merlino A. A case of extensive protein platination: the reaction of lysozyme with a Pt(ii)-terpyridine complex. Dalton Transactions (Cambridge, England : 2003). PMID 29904761 DOI: 10.1039/C8Dt01254G |
0.563 |
|
2018 |
Cilibrizzi A. Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury. Nature Communications. 9: 531. PMID 29416027 DOI: 10.1038/S41467-017-02654-2 |
0.315 |
|
2017 |
Crocetti L, Bartolucci G, Cilibrizzi A, Giovannoni MP, Guerrini G, Iacovone A, Menicatti M, Schepetkin IA, Khlebnikov AI, Quinn MT, Vergelli C. Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors. Chemistry Central Journal. 11: 127. PMID 29214393 DOI: 10.1186/S13065-017-0358-1 |
0.652 |
|
2017 |
Apirakkan O, Frinculescu A, Shine T, Parkin MC, Cilibrizzi A, Frascione N, Abbate V. Analytical characterization of three cathinone derivatives, 4-MPD, 4 F-PHP and bk-EPDP, purchased as bulk powder from online vendors. Drug Testing and Analysis. PMID 28544816 DOI: 10.1002/Dta.2218 |
0.59 |
|
2017 |
Cilibrizzi A, Fedorova M, Collins J, Leatherbarrow R, Woscholski R, Vilar R. A tri-functional vanadium(iv) complex to detect cysteine oxidation. Dalton Transactions (Cambridge, England : 2003). PMID 28513686 DOI: 10.1039/C7Dt00076F |
0.732 |
|
2017 |
Cilibrizzi A, Terenghi M, Fedorova M, Woscholski R, Klug D, Vilar R. Small-molecule optical probes for cell imaging of protein sulfenylation and their application to monitor cisplatin induced protein oxidation Sensors and Actuators B: Chemical. 248: 437-446. DOI: 10.1016/J.Snb.2017.03.171 |
0.718 |
|
2016 |
Vergelli C, Schepetkin IA, Ciciani G, Cilibrizzi A, Crocetti L, Giovannoni MP, Guerrini G, Iacovone A, Kirpotina LN, Ye RD, Quinn MT. Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists. Drug Development Research. PMID 27859446 DOI: 10.1002/Ddr.21370 |
0.669 |
|
2016 |
Wilson N, Mak LH, Cilibrizzi A, Gee AD, Long NJ, Woscholski R, Vilar R. A lipophilic copper(ii) complex as an optical probe for intracellular detection of NO. Dalton Transactions (Cambridge, England : 2003). PMID 27792231 DOI: 10.1039/C6Dt02880B |
0.724 |
|
2016 |
Vergelli C, Schepetkin IA, Ciciani G, Cilibrizzi A, Crocetti L, Giovannoni MP, Guerrini G, Iacovone A, Kirpotina LN, Khlebnikov AI, Ye RD, Quinn MT. 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. Bioorganic & Medicinal Chemistry. PMID 27134116 DOI: 10.1016/J.Bmc.2016.04.019 |
0.656 |
|
2016 |
Collins J, Cilibrizzi A, Fedorova M, Whyte G, Mak LH, Guterman I, Leatherbarrow R, Woscholski R, Vilar R. Vanadyl complexes with dansyl-labelled di-picolinic acid ligands: synthesis, phosphatase inhibition activity and cellular uptake studies. Dalton Transactions (Cambridge, England : 2003). 45: 7104-13. PMID 27008377 DOI: 10.1039/C5Dt04753F |
0.737 |
|
2015 |
Vergelli C, Ciciani G, Cilibrizzi A, Crocetti L, Di Cesare Mannelli L, Ghelardini C, Guerrini G, Iacovone A, Giovannoni MP. Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents. Bioorganic & Medicinal Chemistry. 23: 6237-45. PMID 26361735 DOI: 10.1016/J.Bmc.2015.08.043 |
0.646 |
|
2015 |
Giovannoni MP, Schepetkin IA, Crocetti L, Ciciani G, Cilibrizzi A, Guerrini G, Khlebnikov AI, Quinn MT, Vergelli C. Cinnoline derivatives as human neutrophil elastase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 1-12. PMID 26194018 DOI: 10.3109/14756366.2015.1057718 |
0.677 |
|
2015 |
Giovannoni MP, Ciciani G, Cilibrizzi A, Crocetti L, Daniele S, Di Cesare Mannelli L, Ghelardini C, Giacomelli C, Guerrini G, Martini C, Trincavelli ML, Vergelli C. Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. European Journal of Medicinal Chemistry. 89: 32-41. PMID 25462223 DOI: 10.1016/J.Ejmech.2014.10.020 |
0.649 |
|
2015 |
Giovannoni MP, Ciciani G, Cilibrizzi A, Crocetti L, Daniele S, Di Cesare Mannelli L, Ghelardini C, Giacomelli C, Guerrini G, Martini C, Trincavelli ML, Vergelli C. Further studies on pyrazolo[1′,5′:1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists European Journal of Medicinal Chemistry. 89: 32-41. DOI: 10.1016/j.ejmech.2014.10.020 |
0.584 |
|
2015 |
Vergelli C, Ciciani G, Cilibrizzi A, Crocetti L, Di Cesare Mannelli L, Ghelardini C, Guerrini G, Iacovone A, Giovannoni MP. Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents Bioorganic and Medicinal Chemistry. 23: 6237-6245. DOI: 10.1016/j.bmc.2015.08.043 |
0.614 |
|
2014 |
Schepetkin IA, Khlebnikov AI, Giovannoni MP, Kirpotina LN, Cilibrizzi A, Quinn MT. Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition Current Medicinal Chemistry. 21: 1478-1504. PMID 24350845 DOI: 10.2174/0929867321666131218095521 |
0.648 |
|
2013 |
Crocetti L, Schepetkin IA, Cilibrizzi A, Graziano A, Vergelli C, Giomi D, Khlebnikov AI, Quinn MT, Giovannoni MP. Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase. Journal of Medicinal Chemistry. 56: 6259-72. PMID 23844670 DOI: 10.1021/Jm400742J |
0.662 |
|
2013 |
Cilibrizzi A, Crocetti L, Giovannoni MP, Graziano A, Vergelli C, Bartolucci G, Soldani G, Quinn MT, Schepetkin IA, Faggi C. Synthesis, HPLC enantioresolution, and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists. Chirality. 25: 400-8. PMID 23744588 DOI: 10.1002/Chir.22162 |
0.645 |
|
2013 |
Giovannoni MP, Schepetkin IA, Cilibrizzi A, Crocetti L, Khlebnikov AI, Dahlgren C, Graziano A, Dal Piaz V, Kirpotina LN, Zerbinati S, Vergelli C, Quinn MT. Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. European Journal of Medicinal Chemistry. 64: 512-28. PMID 23685570 DOI: 10.1016/J.Ejmech.2013.03.066 |
0.667 |
|
2013 |
Crocetti L, Vergelli C, Cilibrizzi A, Graziano A, Khlebnikov AI, Kirpotina LN, Schepetkin IA, Quinn MT, Giovannoni MP. Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists Drug Development Research. 74: 259-271. DOI: 10.1002/Ddr.21076 |
0.668 |
|
2012 |
Graziano A, Giovannoni MP, Cilibrizzi A, Crocetti L, Piaz VD, Vergelli C, Trincavelli ML, Martini C, Giacomelli C. New Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones Fluoroderivatives as Human A1 Adenosine Receptor Ligands. Acta Chimica Slovenica. 59: 648-55. PMID 24061322 |
0.614 |
|
2012 |
Cilibrizzi A, Schepetkin IA, Bartolucci G, Crocetti L, Dal Piaz V, Giovannoni MP, Graziano A, Kirpotina LN, Quinn MT, Vergelli C. Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. Bioorganic & Medicinal Chemistry. 20: 3781-92. PMID 22607879 DOI: 10.1016/J.Bmc.2012.04.043 |
0.66 |
|
2012 |
Cilibrizzi A, Isidro-Llobet A, Mateu N, Galloway WRJD, Spring DR. Novel phosphate derivatives as scaffolds for the preparation of synthetic phosphoserine-based peptides using the Fmoc/ t -Bu solid-phase strategy Synlett. 290-294. DOI: 10.1055/S-0031-1290119 |
0.51 |
|
2012 |
Vergelli C, Cilibrizzi A, Crocetti L, Graziano A, Dal Piaz V, Wan B, Wang Y, Franzblau S, Giovannoni MP. Synthesis and Evaluation as Antitubercular Agents of 5-Arylethenyl and 5-(Hetero)aryl-3-Isoxazolecarboxylate Drug Development Research. 74: 162-172. DOI: 10.1002/Ddr.21057 |
0.653 |
|
2011 |
Crocetti L, Giovannoni MP, Schepetkin IA, Quinn MT, Khlebnikov AI, Cilibrizzi A, Piaz VD, Graziano A, Vergelli C. Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase. Bioorganic & Medicinal Chemistry. 19: 4460-72. PMID 21741848 DOI: 10.1016/J.Bmc.2011.06.036 |
0.653 |
|
2011 |
Isidro-Llobet A, Murillo T, Bello P, Cilibrizzi A, Hodgkinson JT, Galloway WR, Bender A, Welch M, Spring DR. Diversity-oriented synthesis of macrocyclic peptidomimetics. Proceedings of the National Academy of Sciences of the United States of America. 108: 6793-8. PMID 21383137 DOI: 10.1073/Pnas.1015267108 |
0.581 |
|
2010 |
Giovannoni MP, Vergelli C, Cilibrizzi A, Crocetti L, Biancalani C, Graziano A, Dal Piaz V, Loza MI, Cadavid MI, Díaz JL, Gavaldà A. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands. Bioorganic & Medicinal Chemistry. 18: 7890-9. PMID 20937560 DOI: 10.1016/J.Bmc.2010.09.043 |
0.642 |
|
2010 |
Biagini P, Biancalani C, Graziano A, Cesari N, Giovannoni MP, Cilibrizzi A, Dal Piaz V, Vergelli C, Crocetti L, Delcanale M, Armani E, Rizzi A, Puccini P, Gallo PM, Spinabelli D, et al. Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity. Bioorganic & Medicinal Chemistry. 18: 3506-17. PMID 20413313 DOI: 10.1016/J.Bmc.2010.03.066 |
0.655 |
|
2010 |
Giovannoni MP, Graziano A, Matucci R, Nesi M, Cesari N, Vergelli C, Biancalani C, Crocetti L, Cilibrizzi A, Dal Piaz V. Synthesis and evaluation as PDE4 inhibitors of pyrimidine-2,4-dione derivatives Drug Development Research. 72: 274-288. DOI: 10.1002/Ddr.20395 |
0.639 |
|
2009 |
Biancalani C, Giovannoni MP, Pieretti S, Cesari N, Graziano A, Vergelli C, Cilibrizzi A, Di Gianuario A, Colucci M, Mangano G, Garrone B, Polenzani L, Dal Piaz V. Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. Journal of Medicinal Chemistry. 52: 7397-409. PMID 19788200 DOI: 10.1021/Jm900458R |
0.621 |
|
2009 |
Cilibrizzi A, Quinn MT, Kirpotina LN, Schepetkin IA, Holderness J, Ye RD, Rabiet MJ, Biancalani C, Cesari N, Graziano A, Vergelli C, Pieretti S, Dal Piaz V, Giovannoni MP. 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors. Journal of Medicinal Chemistry. 52: 5044-57. PMID 19639995 DOI: 10.1021/Jm900592H |
0.66 |
|
Show low-probability matches. |